MDB Capital Announces Record Date Of July 22, 2024 For IPO Of 4.3M Shares Of Common Stock For Invizyne Technologies At A Price Of $4/Share
MDB Capital Announces Record Date Of July 22, 2024 For IPO Of 4.3M Shares Of Common Stock For Invizyne Technologies At A Price Of $4/Share
- Record date of July 22, 2024 set for allocation preferences
- Closing and trading expected on NASDAQ on or before August 15
- 2024年7月22日設定分配偏好的記錄日期。
- 預計在或者在8月15日前於納斯達克關閉和交易。
Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, today announces the record date, allocation preference, and expected timeline for the proposed offering for Invizyne Technologies, Inc.
2024年7月11日得克薩斯州艾迪遜（GLOBE NEWSWIRE）- MDb Capital Holdings，LLC，（NASDAQ：MDBH）（“MDB”），一家公共創業平台，專注於推出領先的深科技公司，今天宣佈了Invizyne Technologies，Inc.擬議中發行的記錄日期、分配偏好和預期時間表。
In February 2024, Invizyne – a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life and a subsidiary of MDB Capital Holdings – filed its IPO registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") for the sale of its common stock in a firm commitment public offering.
2024年2月，Invizyne – 一家領先的電芯無細胞、基於酶的生物製造系統設計公司，專門爲生產日常生活中的商業化重要分子和化學藥品，是MDB Capital Holdings的子公司-以形式S-1向美國證券交易委員會（“SEC”）提交其首次公開發行註冊聲明，出售其普通股。